Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
eTheRNA immunotherapies
company
About
eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- €1M
- Industries
- Biotechnology,Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA’s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient’s immune system than any other similar approach investigated until now.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€1M
eTheRNA immunotherapies has raised a total of
€1M
in funding over 2 rounds. Their latest funding was raised on
Sep 25, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 25, 2017 | Grant | €1M | 1 |
The Institute for the Promotion of Innovation by Science and Technology in Flanders
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
eTheRNA immunotherapies has made 2 investments. Their most recent investment was on
Sep 16, 2013, when Armory Technologies, Inc. raised $600K.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 16, 2013
Armory Technologies, Inc.
|
Seed | $600K | Bitcoin | — |
|
Jan 7, 2013
BitPay
|
Seed | $510K | Bitcoin | — |
Investors
Number of Lead Investors
Number of Investors
1
1
eTheRNA immunotherapies is funded by 1 investors.
The Institute for the Promotion of Innovation by Science and Technology in Flanders
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
The Institute for the Promotion of Innovation by Science and Technology in Flanders
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
